Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Retained Earnings / (Deficit)
Balance, beginning of period (in shares) at Jun. 30, 2022		18,247,000
Balance, beginning of period at Jun. 30, 2022	$ 113,459	$ 2	$ (3,406)	$ 197,785	$ (4,562)	$ (76,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	31,582					31,582
Foreign currency translation adjustment	(2,234)				(2,234)
Changes in fair value of cash flow hedges	515				515
Purchase of treasury shares (in shares)		(18,000)
Purchase of treasury shares	(276)		(276)
Changes in defined benefit plan	$ (31)				(31)
Forfeiture of restricted common shares (in shares)	(72,000)
Provision for common stock warrants	$ 1,090			1,090
Issue of common shares related to option issuances (in shares)		123,000
Issue of common shares related to option issuances	2,053			2,053
Stock based compensation expense	3,806			3,806
Balance, end of period (in shares) at Jun. 30, 2023		18,280,000
Balance, end of period at Jun. 30, 2023	149,964	$ 2	(3,682)	204,734	(6,312)	(44,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	33,655					33,655
Foreign currency translation adjustment	(1,623)				(1,623)
Changes in fair value of cash flow hedges	(111)				(111)
Purchase of treasury shares (in shares)		(1,322,000)
Purchase of treasury shares	(21,685)		(21,685)
Changes in defined benefit plan	133				133
Provision for common stock warrants	1,183			1,183
Issue of common shares related to option issuances (in shares)		59,000
Issue of common shares related to option issuances	366			366
Stock based compensation expense	$ 3,917			3,917
Balance, end of period (in shares) at Jun. 30, 2024	17,017,476	17,017,000
Balance, end of period at Jun. 30, 2024	$ 165,799	$ 2	(25,367)	210,200	(7,913)	(11,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	36,864					36,864
Foreign currency translation adjustment	1,114				1,114
Changes in fair value of cash flow hedges	775				775
Purchase of treasury shares (in shares)		(3,948,000)
Purchase of treasury shares	(77,972)	$ (1)	(77,971)
Changes in defined benefit plan	(312)				(312)
Issue of common shares related to option issuances (in shares)		289,000
Issue of common shares related to option issuances	4,307			4,307
Stock based compensation expense	$ 3,734			3,734
Balance, end of period (in shares) at Jun. 30, 2025	13,357,990	13,358,000
Balance, end of period at Jun. 30, 2025	$ 134,309	$ 1	$ (103,338)	$ 218,241	$ (6,336)	$ 25,741